Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
At the highest dose studied (12mg), 100% of participants achieved at least 5% weight loss and 26% achieved more than 30% weight loss, figures not seen with any previously studied compound in this class
Once you have reached your weight loss goals we will formulate a plan for maintenance of your success
Archived from the original on 7 March 2023
[1] NICE guidance (NG28) recommends GLP-1 receptor agonists like semaglutide for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is ineffective, not tolerated, or contraindicated The person has a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific psychological or medical problems associated with obesity BMI is lower than 35 kg/m but insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities Ozempic is available in pre-filled, multi-dose pens delivering 0.25 mg, 0.5 mg, 1 mg, or 2 mg doses
In recent years, GLP-1 (glucagon-like peptide-1) receptor agonists have surged in popularity for their role in managing weight loss and metabolic health
US$ 22.92
US$ 22.13
US$ 26.26
US$ 29.11
